Search Login Register

gemtuzumab (gemtuzumab ozogamicin) Summary

Description: an anti-CD33 antibody calicheamicin conjugate

Also Known As: gemtuzumab ozogamicin; Mylotarg; CMA 676; CMA-676; Wyeth brand of gemtuzumab ozogamicin Show All >>

Networked: 281 relevant articles (44 outcomes, 60 trials/studies) for this Drug

Key Diseases for which gemtuzumab is Relevant

  1. Acute Myeloid Leukemia (Acute Myelogenous Leukemia) : 30 outcomes 53 studies in 201 results
  2. Acute Promyelocytic Leukemia : 8 outcomes 2 studies in 25 results
  3. Leukemia : 1 outcome 8 studies in 24 results
  4. Neoplasms (Cancer) : 1 outcome 3 studies in 16 results
  5. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) : 1 outcome 1 study in 7 results
Show All >>

Drugs Related to gemtuzumab

  1. gemtuzumab (gemtuzumab ozogamicin)
  2. Cytarabine (Cytosar-U)
  3. Tretinoin (Retinoic Acid)
  4. Azacitidine (5 Azacytidine)
  5. vorinostat (suberoylanilide hydroxamic acid)
  6. Mitoxantrone (Novantrone)
  7. fludarabine
  8. Hydroxyurea (Hydrea)
  9. Cyclosporine (Ciclosporin)
  10. Immunotoxins (Immunotoxin)
Show All >>

Therapies Related to gemtuzumab

  1. Drug Therapy (Chemotherapy)
  2. Transplantation (Transplant Recipients)
  3. Remission Induction
  4. Transplants (Transplant)
  5. Hematopoietic Stem Cell Transplantation
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.